Detectable size of melanoma metastases to brain on PET/CT

被引:2
作者
Oldan, Jorge D. [1 ]
Glaubiger, Samuel A. [1 ]
Khandani, Amir H. [1 ]
Jewells, Valerie L. [1 ]
机构
[1] Chapel Hill Hosp, UNC Dept Radiol, 101 Manning Dr, Chapel Hill, NC 27514 USA
关键词
Melanoma; PET; CT; Brain metastases; HEAD;
D O I
10.1007/s12149-020-01481-8
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Objective We aimed to determine at what size melanoma metastases become detectable by PET/CT. Methods We reviewed a total of 293 whole-body PET/CT studies performed on 212 patients for staging of melanoma where there was an MRI within a month of the PET/CT. MR and PET/CT were reviewed independently by separate readers. Results PET/CT revealed an overall incidental true-positive rate of 1% on a per-patient basis, consistent with other studies, with 'hot' lesions (more avid than brain parenchyma) visible at smaller sizes than 'cold' lesions. Conclusions PET/CT can detect metastatic melanoma lesions over about 2 cm in size, with hot lesions generally visible at smaller sizes.
引用
收藏
页码:545 / 548
页数:4
相关论文
共 50 条
  • [21] How I treat brain metastases of melanoma
    Eroglu, Z.
    Topcu, T. O.
    Yu, H. M.
    Margolin, K. A.
    ESMO OPEN, 2022, 7 (06)
  • [22] Ipilimumab and radiation therapy for melanoma brain metastases
    Silk, Ann W.
    Bassetti, Michael F.
    West, Brady T.
    Tsien, Christina I.
    Lao, Christopher D.
    CANCER MEDICINE, 2013, 2 (06): : 899 - 906
  • [23] Predictors and survival in patients with melanoma brain metastases
    Ugo Bottoni
    Rita Clerico
    Giovanni Paolino
    Marina Ambrifi
    Paola Corsetti
    Stefano Calvieri
    Medical Oncology, 2013, 30
  • [24] Vemurafenib and radiation therapy in melanoma brain metastases
    Narayana, Ashwatha
    Mathew, Maya
    Tam, Moses
    Kannan, Rajni
    Madden, Kathleen M.
    Golfinos, John G.
    Parker, Erik C.
    Ott, Patrick A.
    Pavlick, Anna C.
    JOURNAL OF NEURO-ONCOLOGY, 2013, 113 (03) : 411 - 416
  • [25] Vemurafenib and radiation therapy in melanoma brain metastases
    Ashwatha Narayana
    Maya Mathew
    Moses Tam
    Rajni Kannan
    Kathleen M. Madden
    John G. Golfinos
    Erik C. Parker
    Patrick A. Ott
    Anna C. Pavlick
    Journal of Neuro-Oncology, 2013, 113 : 411 - 416
  • [26] Melanoma patient with brain metastases treated with immunothernpy
    Jankowski, Tomasz
    ONCOLOGY IN CLINICAL PRACTICE, 2018, 14 : A16 - A18
  • [27] Ipilimumab and whole brain radiation therapy for melanoma brain metastases
    Gerber, Naamit K.
    Young, Robert J.
    Barker, Christopher A.
    Wolchok, Jedd D.
    Chan, Timothy A.
    Yamada, Yoshiya
    Friguglietti, Leigh
    Beal, Kathryn
    JOURNAL OF NEURO-ONCOLOGY, 2015, 121 (01) : 159 - 165
  • [28] PET/CT variants and pitfalls in malignant melanoma
    Aide, Nicolas
    Iravani, Amir
    Prigent, Kevin
    Kottler, Diane
    Alipour, Ramin
    Hicks, Rodney J.
    CANCER IMAGING, 2022, 22 (01)
  • [29] Ipilimumab and whole brain radiation therapy for melanoma brain metastases
    Naamit K. Gerber
    Robert J. Young
    Christopher A. Barker
    Jedd D. Wolchok
    Timothy A. Chan
    Yoshiya Yamada
    Leigh Friguglietti
    Kathryn Beal
    Journal of Neuro-Oncology, 2015, 121 : 159 - 165
  • [30] Utility of PET/CT in patients with stage I-III melanoma
    Aviles Izquierdo, J. A.
    Molina Lopez, I.
    Sobrini Morillo, P.
    Marquez Rodas, I.
    Mercader Cidoncha, E.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2020, 22 (08) : 1414 - 1417